Cardiovascular Safety : The cardiovascular safety of tirzepatide has been evaluated and confirmed to date through a pre-specified meta-analysis of phase 2 and 3 randomized trials comparing tirzepatide with other placebo, insulin glargine, degludec, semaglutide, dulaglutide for a minimum of 26 weeks (including the GPGB, SURPASS 1,2,3,4,5, and J-mono studies) [67]
lobata shows promise in both general health maintenance and specific therapeutic uses, particularly in diabetes and its consequences
Neurotoxicol Teratol 36:4756
Research subjects report that the metallic aftertaste persists for 2040 minutes after sublingual administration, even after rinsing with water or consuming flavored beverages